3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
3
Lung Neoplasms
3
Colitis
3
Urogenital Neoplasms
2
Solid Carcinoma
2
Diarrhea
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Gastrointestinal Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Advanced Gastric Cancer
1
Interventions
Bevacizumab
47
lenvatinib
36
atezolizumab
36
durvalumab
28
tremelimumab
23
sintilimab
19
Nivolumab
18
pembrolizumab
14
Radiosurgery
13
tislelizumab
11
Specimen Handling
10
Ipilimumab
10
camrelizumab
8
apatinib
8
Oxaliplatin
8
Immune Checkpoint Inhibitors
8
Fluorouracil
8
Cyclophosphamide
8
Blood Specimen Collection
8
regorafenib
7
cabozantinib
7
fludarabine
6
Sorafenib
6
Radiotherapy
6
Magnetic Resonance Spectroscopy
6
Leucovorin
6
donafenib
5
Surgical Procedures, Operative
5
Injections
5
Immunoglobulin G
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Hepatocellular
×
Fecal Microbiota Transplantation
×
Clear all
NCT05690048
2025-08-06
FLORA
University Hospital Heidelberg
Phase 2
Recruiting
48 enrolled